✦ LIBER ✦

Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells

✍ Scribed by Teresa L. Fuller; Robert G. Canada

Publisher: Springer
Year: 1999
Tongue: English
Weight: 87 KB
Volume: 44
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050974

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of terbium on the cellular a

The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells

✍ Kelly M. Mack; R. G. Canada; Paul A. Andrews 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 356 KB

Enhancement of cisplatin activity by lon

Enhancement of cisplatin activity by lonidamine in human ovarian cancer cells

✍ Rosella Silvestrini; Nadia Zaffaroni; Raffaella Villa; Linda Orlandi; Aurora Cos 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 524 KB

The ability of lonidamine, an energolytic derivative of indazolecarboxylic acid, to modulate the cytotoxicity of cisplatin was investigated in human ovarian-cancer cell lines sensitive (A2780) or with experimentally induced resistance (A2780/cp8) to the alkylating agent. A 24-hr post-incubation with

Characterizations of irofulven cytotoxic

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells

✍ Maria Serova; Fabien Calvo; François Lokiec; Florence Koeppel; Virginie Poindess 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 362 KB

Enhancement of cisplatin sensitivity by

Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression

✍ Dilip Jain; Nila Patel; Melanie Shelton; Alakananda Basu; Rouel Roque; Wolfram S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 414 KB

Protection of platinum–DNA adduct format

Protection of platinum–DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells

✍ Verena Materna; Bernd Liedert; Jürgen Thomale; Hermann Lage 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 411 KB

## Abstract Resistance to platinum‐containing antineoplastic drugs is the major limitation in their clinical use. To elucidate the role of the ABC transporter MRP2 in platinum drug resistance, its expression was analyzed in human cisplatin‐resistant cell lines: the ovarian carcinoma line A2780RCIS,